Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Arrowhead Pharmaceuticals (ARWR) over the last 11 years, with Q4 2025 value amounting to 0.13.

  • Arrowhead Pharmaceuticals' Debt Ratio fell 6865.14% to 0.13 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.13, marking a year-over-year decrease of 6865.14%. This contributed to the annual value of 0.18 for FY2025, which is 4666.24% down from last year.
  • As of Q4 2025, Arrowhead Pharmaceuticals' Debt Ratio stood at 0.13, which was down 6865.14% from 0.18 recorded in Q3 2025.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Debt Ratio peaked at 0.4 during Q4 2024, and registered a low of 0.13 during Q4 2025.